Data as of Mar 10
| +0.14 / +0.51%|
The 10 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 25.50, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a -7.58% decrease from the last price of 27.59.
The current consensus among 12 polled investment analysts is to Buy stock in Impax Laboratories Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.